CFM
TELA icon

Catalyst Funds Management’s TELA Bio TELA Stock Holding History

Catalyst Funds Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,000
Closed -$10.1K – 1174
2024
Q3 		$10.1K Hold
4,000
– – ﹤0.01% 1186
2024
Q2 		$18.8K Buy
+4,000
New +$21.1K 0.01% 703

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Catalyst Funds Management's TELA Position: Q4 2024 in Review

Catalyst Funds Management sold out of TELA Bio (TELA) in Q4 2024, closing a stake of 4,000 shares — an estimated $10.1K sold.

Catalyst Funds Management first reported a position in TELA in Q2 2024 and held it in 2 quarters. The position peaked at $18.8K in Q2 2024. 47 funds tracked by Wall St. Rank hold TELA as of Q4 2024.

  • Catalyst Funds Management reported no remaining TELA Bio position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 4,000 TELA Bio shares in Q4 2024, an estimated $10.1K.
  • Catalyst Funds Management first reported a position in TELA Bio in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's TELA Bio position peaked at $18.8K in Q2 2024.
  • 47 funds tracked by Wall St. Rank held TELA Bio as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.